Journal of Multiple Sclerosis and Neuroimmunology

Case Report: J Mult Scler Neuroimmunol. 2022;13(2):35-38. Published online December 31, 2022.; 고용량 스테로이드로 치료한 무증상 COVID-19 감염 이후 파킨슨증; 강유진^a, 구가은^a, 추이슬^a, 원문호^b, 박찬영^a; ¹중앙대병원 신경과
²중앙대병원 응급의학과; A Case of Parkinsonism after Asymptomatic COVID-19 Infection Treated with High-Dose Corticosteroid; Yu-Jin Kang^a, Ga Eun Koo^a, Yi-Seul Choo^a, Moonho Won^b, Chan-Young Park^a; ¹Departments of Neurology, Chung-Ang University Hospital, Seoul, Korea
²Emergency Medicine, Chung-Ang University Hospital, Seoul, Korea; Corresponding author: Chan-Young Park Tel: +82-2-6299-1488, Fax: +82-2-6298-8351, Email: park.cy.1206@gmail.com; Received: November 27, 2022; Revised: December 9, 2022 Accepted: December 19, 2022.

Abstract: COVID-19 is a virus that primarily causes respiratory illness. However, there is increasing evidence regarding neuropathic presentation of the virus. Neurologic symptoms have been reported to range from headache, ageusia, and anosmia to encephalitis, myelitis, and cerebrovascular disease. Here, we report a patient with acute onset parkinsonism with bilateral abnormalities of the basal ganglia after asymptomatic COVID-19 infection who was successfully treated with high-dose corticosteroid. Journal of Multiple Sclerosis and Neuroimmunology 13(2):35-38, 2022

Keywords :Parkinsonism; COVID-19